{"id":113,"date":"2019-09-02T12:02:39","date_gmt":"2019-09-02T12:02:39","guid":{"rendered":"https:\/\/xspraypharma.com\/?page_id=113"},"modified":"2025-08-20T13:03:47","modified_gmt":"2025-08-20T13:03:47","slug":"valberedning","status":"publish","type":"page","link":"https:\/\/xspraypharma.com\/sv\/investerare\/bolagsstyrning\/valberedning\/","title":{"rendered":"Valberedning"},"content":{"rendered":"<section class=\"block content-block\">\n\t\t\t\t\t\t<div class=\"container-fluid container-small editor_content\">\n\t\t\t\t<h1>Valberedning<\/h1>\n<p>Valberedningen representerar bolagets aktie\u00e4gare. Den har till uppgift att, inf\u00f6r \u00e5rsst\u00e4mma i bolaget, bereda f\u00f6rslag till beslut om bland annat styrelsens sammans\u00e4ttning, extern revisor samt om ers\u00e4ttning till dessa, samt, i f\u00f6rekommande fall, procedurfr\u00e5gor f\u00f6r n\u00e4stkommande valberedning.<\/p>\n<p>Valberedning \u00e4r sammansatt av styrelsens ordf\u00f6rande och ledam\u00f6ter som utsetts av de fyra st\u00f6rsta aktie\u00e4garna i bolaget, baserat p\u00e5 \u00e4gande i bolaget den 31 augusti. Om n\u00e5gon av de fyra st\u00f6rsta aktie\u00e4garna avst\u00e5r fr\u00e5n sin r\u00e4tt att utse en representant till valberedningen, ska s\u00e5dan r\u00e4tt \u00f6verl\u00e5tas till den aktie\u00e4gare som i sin tur efter dessa fyra \u00e4r den st\u00f6rsta aktie\u00e4garen i bolaget. Ordf\u00f6rande f\u00f6r valberedningen ska vara den person som representerar den st\u00f6rsta aktie\u00e4garen i f\u00f6rh\u00e5llande till antal r\u00f6ster.<\/p>\n<p>Kallelsen offentligg\u00f6rs genom ett pressmeddelande och kung\u00f6rs i Post och Inrikes Tidningar, i Svenska Dagbladet samt publiceras p\u00e5 Xsprays hemsida.<\/p>\n<p>Aktie\u00e4gare som vill ha en fr\u00e5ga behandlad p\u00e5 \u00e5rsst\u00e4mman ska inkomma med en skriftlig beg\u00e4ran till valberedningen senast sju veckor f\u00f6re st\u00e4mman. Valberedningen kan kontaktas genom e-post till: <a href=\"mailto:generalmeeting@xspray.com\">generalmeeting@xspray.com<\/a>.<\/p>\n<p>Valberedningen inf\u00f6r bolagsst\u00e4mma den 13 maj 2025 best\u00e5r av:<\/p>\n<ul>\n<li>Thomas Eldered, utsedd av Flerie AB<\/li>\n<li>Johan Gyllensw\u00e4rd, utsedd av Ribbskottet AB<\/li>\n<li>Mattias Klintemar, utsedd av \u00d6stersj\u00f6stiftelsen<\/li>\n<li>Johan Wadell, utsedd av AP2<\/li>\n<li>Anders Ekblom, Styrelseordf\u00f6rande, Xspray Pharma AB<\/li>\n<\/ul>\n\t\t\t<\/div>\n\t\t\t<\/section>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":87,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-113","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Valberedning - Xspray<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/xspraypharma.com\/sv\/investerare\/bolagsstyrning\/valberedning\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Valberedning - Xspray\" \/>\n<meta property=\"og:url\" content=\"https:\/\/xspraypharma.com\/sv\/investerare\/bolagsstyrning\/valberedning\/\" \/>\n<meta property=\"og:site_name\" content=\"Xspray\" \/>\n<meta property=\"article:modified_time\" content=\"2025-08-20T13:03:47+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/xspraypharma.com\/sv\/investerare\/bolagsstyrning\/valberedning\/\",\"url\":\"https:\/\/xspraypharma.com\/sv\/investerare\/bolagsstyrning\/valberedning\/\",\"name\":\"Valberedning - Xspray\",\"isPartOf\":{\"@id\":\"https:\/\/xspraypharma.com\/sv\/#website\"},\"datePublished\":\"2019-09-02T12:02:39+00:00\",\"dateModified\":\"2025-08-20T13:03:47+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/xspraypharma.com\/sv\/investerare\/bolagsstyrning\/valberedning\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/xspraypharma.com\/sv\/investerare\/bolagsstyrning\/valberedning\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/xspraypharma.com\/sv\/investerare\/bolagsstyrning\/valberedning\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/xspraypharma.com\/sv\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Investerare\",\"item\":\"https:\/\/xspraypharma.com\/sv\/investerare\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Bolagsstyrning\",\"item\":\"https:\/\/xspraypharma.com\/sv\/investerare\/bolagsstyrning\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Valberedning\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/xspraypharma.com\/sv\/#website\",\"url\":\"https:\/\/xspraypharma.com\/sv\/\",\"name\":\"Xspray\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/xspraypharma.com\/sv\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Valberedning - Xspray","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/xspraypharma.com\/sv\/investerare\/bolagsstyrning\/valberedning\/","og_locale":"sv_SE","og_type":"article","og_title":"Valberedning - Xspray","og_url":"https:\/\/xspraypharma.com\/sv\/investerare\/bolagsstyrning\/valberedning\/","og_site_name":"Xspray","article_modified_time":"2025-08-20T13:03:47+00:00","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/xspraypharma.com\/sv\/investerare\/bolagsstyrning\/valberedning\/","url":"https:\/\/xspraypharma.com\/sv\/investerare\/bolagsstyrning\/valberedning\/","name":"Valberedning - Xspray","isPartOf":{"@id":"https:\/\/xspraypharma.com\/sv\/#website"},"datePublished":"2019-09-02T12:02:39+00:00","dateModified":"2025-08-20T13:03:47+00:00","breadcrumb":{"@id":"https:\/\/xspraypharma.com\/sv\/investerare\/bolagsstyrning\/valberedning\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/xspraypharma.com\/sv\/investerare\/bolagsstyrning\/valberedning\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/xspraypharma.com\/sv\/investerare\/bolagsstyrning\/valberedning\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/xspraypharma.com\/sv\/"},{"@type":"ListItem","position":2,"name":"Investerare","item":"https:\/\/xspraypharma.com\/sv\/investerare\/"},{"@type":"ListItem","position":3,"name":"Bolagsstyrning","item":"https:\/\/xspraypharma.com\/sv\/investerare\/bolagsstyrning\/"},{"@type":"ListItem","position":4,"name":"Valberedning"}]},{"@type":"WebSite","@id":"https:\/\/xspraypharma.com\/sv\/#website","url":"https:\/\/xspraypharma.com\/sv\/","name":"Xspray","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/xspraypharma.com\/sv\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"}]}},"_links":{"self":[{"href":"https:\/\/xspraypharma.com\/sv\/wp-json\/wp\/v2\/pages\/113","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/xspraypharma.com\/sv\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/xspraypharma.com\/sv\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/xspraypharma.com\/sv\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/xspraypharma.com\/sv\/wp-json\/wp\/v2\/comments?post=113"}],"version-history":[{"count":38,"href":"https:\/\/xspraypharma.com\/sv\/wp-json\/wp\/v2\/pages\/113\/revisions"}],"predecessor-version":[{"id":10950,"href":"https:\/\/xspraypharma.com\/sv\/wp-json\/wp\/v2\/pages\/113\/revisions\/10950"}],"up":[{"embeddable":true,"href":"https:\/\/xspraypharma.com\/sv\/wp-json\/wp\/v2\/pages\/87"}],"wp:attachment":[{"href":"https:\/\/xspraypharma.com\/sv\/wp-json\/wp\/v2\/media?parent=113"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}